News
GC Biopharma Gets India, Taiwan Nod for Hunter Syndrome Drug Hunterase
Following the latest approvals in India and Taiwan, GC Biopharma’s Hunter syndrome treatment, Hunterase IV, is now authorized in 14 countries.
imphoenix82
- August 24, 2026
- 0 Comments
- 18 Views
-
